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Abstract
Background: Multimorbid patients may experience a high burden of treatment. This has a negative impact on
treatment adherence, health outcomes and health care costs. The objective of our study was to identify factors
associated with the self-perceived burden of treatment of multimorbid patients in primary care and to compare
them with factors associated with GPs assessment of this burden.
Method: A cross sectional study in general practices, 100 GPs in Switzerland and up to 10 multimorbid patients per
GP. Patients reported their self-perceived burden of treatment using the Treatment Burden Questionnaire (TBQ,
possible score 0–150), whereas GPs evaluated the burden of treatment on a Visual Analog Scale (VAS) from 1 to 9.
The study explored medical, social and psychological factors associated with burden of treatment, such as number
and type of chronic conditions and drugs, severity of chronic conditions (CIRS score), age, quality of life,
deprivation, health literacy.
Results: The GPs included 888 multimorbid patients. The overall median TBQ was 20 and the median VAS was 4.
Both patients’ and GPs’ assessment of the burden of treatment were inversely associated with patients’ age and
quality of life. In addition, patients’ assessment of their burden of treatment was associated with a higher
deprivation score and lower health literacy, and with having diabetes or atrial fibrillation, whereas GPs’ assessment
of this burden was associated with the patient having a greater number of chronic conditions and drugs, and a
higher CIRS score.
Conclusion: Both from patients’ and GPs’ perspectives TB appears to be higher in younger patients. Whereas for
patients the burden of treatment is associated with socio-economic and psychological factors, GPs’ assessments of
this burden are associated with medical factors. Including socio-economic and psychological factors on patients’
self-perception is likely to improve GPs’ assessments of their patients’ burden of treatment thus favoring patient-
centered care.
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Background
Multimorbidity (commonly defined as having two or
three chronic conditions) is increasing in prevalence and
becoming a major health concern worldwide. [1–3] It is
associated with a higher burden of disease, poorer health
outcomes and reduced quality of life, more frequent hos-
pital admissions, a higher number of provider visits,
higher mortality and increasing healthcare costs. [4–8]
Multimorbity is also associated with polypharmacy and
its potentially negative consequences on safety of care
(e.g. drug interactions). [9, 10] The prevalence of multi-
morbidity is high in primary care (PC) and these patients
require long-term care. [11]
Physicians increasingly encourage multimorbid patients
to develop self-management skills. For patients this involves
finding time for health education, lifestyle changes, self-
assessment and monitoring. Self-management in the con-
text of multimorbidity has important implications for the
organization of patients’ daily lives. [12, 13] In other words,
multiple chronic conditions are associated with the “work
to be patient”, also called burden of treatment (which is not
the same as the burden of diseases). [14, 15] Burden of
treatment has an impact on adherence to treatment. The
higher the burden of treatment, the higher the need for pa-
tients to invest time in acquiring knowledge about their dis-
eases and their relevant treatment options. [12, 16, 17]
Burden of treatment is a recent concept, initially intro-
duced for single chronic conditions, and then for single
chronic conditions in combination with co-morbidities.
[18] It is not defined very clearly, and there are consider-
able variations between authors, studied populations and
countries. [19, 20] To date, most studies on burden of
treatment are qualitative in nature, and include the study
of different aspects of daily life such as financial burden,
lack of knowledge, time spent for diet and exercises,
medication burden and frequent healthcare appoint-
ments. [19, 21] In 2012, based on these qualitative stud-
ies, Tran et al. proposed a quantitative measure to assess
patients’ self-perceived burden of treatment: the Treat-
ment Burden Questionnaire (TBQ). [14]
Little evidence is available in relation to the factors associ-
ated with the burden of treatment for multimorbid patients
in primary care. Some studies have identified physical, fi-
nancial, time and psychosocial factors [19, 22, 23]. Different
studies also suggest an association with socio-economic de-
terminants and social deprivation. [16] The association be-
tween patient characteristics and burden of treatment has
not been explored before. Knowledge of these factors could
guide GPs in identifying patients exposed to a higher bur-
den of treatment.
Therefore, the aim of our study was to describe the
medical, psychological and socio-economic factors asso-
ciated with patients’ self-perceived burden of treatment.
A secondary aim was to compare these factors with
those associated with GPs’ assessment of their patients’
burden of treatment, in order to formulate hypotheses
about the extent to which GPs’ assessment of this bur-
den might favor patient-centered care.
Method
Our analyses are based on the cross-sectional study
“Multi-Morbidity in Family Medicine” (MMFM). The
detailed study protocol and the first results have been
published elsewhere. [24, 25] Briefly, MMFM included
888 multimorbid patients in primary care and involved a
convenience sample of 100 GPs across five large regions
in Switzerland. Eligible participants were multimorbid
patients aged over 18 years old, suffering from at least
three chronic conditions identified in a predefined list of
75 items based on the International Classification of Pri-
mary Care 2, (ICPC-2). [26] Each included patient gave
his or her written informed consent. GPs completed a
written form, whereas patients answered a standardized
telephone interview conducted by trained research col-
laborators. Interviews were conducted in French or Ger-
man depending on the region of Switzerland in which
the patient lived. [24, 25]
Ethical approval
The Human Research Ethics Committee of the Canton
of Vaud, acting as the lead ethics committee for
Switzerland (Protocol 315/14), approved the protocol.
We evaluated the burden of treatment from two
perspectives:
From the patient’s perspective
We used the above-mentioned validated questionnaire,
the TBQ. [14] The TBQ was first published and validated
in French. We followed standard steps to create a German
version: parallel translation by two professional transla-
tors, consolidation and back translation. [27] We chose
the TBQ in 2013, when the protocol was established, be-
cause it was then the only existing score. We used 15
items-version of the French validation. (Additional file 1).
The TBQ-score is computed by simply adding patients’
answers for each item on a 10-point Likert scale. Conse-
quently, the TBQ score ranges between 0 (no burden) and
150 (highest burden).
From the GP’s perspective
GPs estimated the burden of treatment for each patient
they had included on a VAS scale from 1 to 9 where 1 is
the lowest and 9 the highest burden.
In addition, the following variables were analyzed
Patient’s age and gender, the number of chronic condi-
tions and drugs (as reported by GPs), the severity of
chronic conditions as assessed by GPs on the
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Cumulative Illness Rating Scale (CIRS) [28], patients’
quality of life (EQ. 5D 3 L) [29], their health literacy (HL
score) [30], level of deprivation (DipCare score) [31]. We
also examined the association between the burden of
treatment and the presence of specific chronic condi-
tions, choosing conditions that had a prevalence > 20%
in our sample: hypertension (ICPC2 codes K85,86), car-
diovascular risk factors (K22), diabetes (T89, 90), obesity
(T82) ischemic heart diseases (K 74, 76), depression (P76)
osteoarthritis of the knee (L90), general pain (A01) and
atrial fibrillation (K78). (Also see results Table 1). We
choose a cut-off of 20% to include the chronic conditions
in the regression model in order to limit the number of
variables to include with the aim to avoid overfitting.
Statistical analyses
We conducted descriptive analyses, presented as mean,
standard deviation, median and interquartile range for
quantitative variables and as frequencies and proportions
for categorical variables.
Univariate and multivariate linear regressions were
conducted to determine which factors were associated
with our two outcomes, i.e. TBQ scores for the patient
and VAS scores for GPs. As the TBQ was asymmetrically
distributed in our sample, a logarithmic transformation
of the latter was considered as the dependent variable in
the regression. The GP-cluster effect was introduced
into the model as a random intercept. Multiple imputa-
tions by fully conditional specification were used to han-
dle missing values. Each missing value was imputed 15
times. To avoid overfitting, we proceeded to a forward
selection of the independent variables in both multivari-
able regressions (TBQ and VAS). At each step of the se-
lection, for each new variable to be included, the null
hypothesis was tested that the extra parameter was zero.
The variable corresponding to the smallest p-value was
included in the model. The selection procedure was
interrupted when no p-value was lesser or equal to 0.1.
As the research team suspected an association between
the number of chronic conditions, the number of drugs
and the CIRS (calculated as the ratio of total score/num-
ber of endorsed categories) and the burden of treatment,
these variables were included in the model before start-
ing the forward selection procedure. Finally, we com-
puted the variance inflation factor (VIF) of the selected
variables to ensure their non-collinearity.
Dependent variables
Log (TBQ score + 1), VAS scale.
Independent variables
All variables described in Table 1, except for the two
dependent variables.
All analyses were conducted using R version 3.4.4 and
the package mice version 2.46 for the imputation of
missing values. [32, 33]
Results
We included 888 patients (mean age of 72.9 years, 48%
were men). They had a mean of 7.2 chronic conditions
(SD 2.9) and were taking a mean of 7.5 pills a day (SD 3.5)
. Patients’ characteristics and factors associated with the
TBQ (Mean (SD), Median (IQR), Frequency and Percent-
age) are listed in Table 1. We created a correlation matrix,
which can be found in the additional file (Additional file 2)
.
Patients’ perspective
The overall median TBQ score was 20 (Q25% = 15,
Q75% = 33). The distribution is shown in Figs. 1 and 2.
The results of the regressions are shown in Table 2.
The effect size is given on the logarithmic scale. The for-
ward selection process led to the inclusion of age, educa-
tion, use of a pillbox, quality of life (EQ5D3L_score and
EQ5D3L VAS), DipCare index, health literacy, diabetes
and atrial fibrillation in the multivariable model (as pre-
viously stated, number of chronic conditions, CIRCS (ra-
tio total score/number of endorsed categories) and
number of drugs were included in the model before the
selection). Variance inflation factors were relatively low.
There is thus no major collinearity between the variables
introduced in the model. Younger age, higher education,
higher deprivation score, lower quality of life and health
literacy scores were significantly associated with higher
TBQ scores. Furthermore, patients with diabetes or
atrial fibrillation had higher TBQ scores. We found no
association between depression (P76), general pain (A01)
or the CIRCS, and TBQ scores.
GPs’ perspective
The median VAS rating was 4 (Q25% = 3, Q75% = 6).
The results of the regressions are shown in Table 3 and
the distribution is shown in Fig. 3. Forward selection re-
sulted in the inclusion of age, use of a pillbox, home-
based care, quality of life (eq5d3l score and eq5d3l VAS),
health literacy, general pain and atrial fibrillation in the
multivariable model (again, number of chronic condi-
tions, CIRS and number of drugs were included in the
model before the selection). We found an association be-
tween a higher VAS rating and lower age, higher number
of chronic conditions and drugs, higher CIRCS and a
lower quality of life score.
Discussion
Our study analyzed factors associated with multimorbid
patients’ self-perceived burden of treatment as well as
factors associated with GPs’ assessment of this burden.
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Table 1 Characteristics of the 888 included patients and main results regarding associated factors
Description Type N missing
values
Value Frequency* Percentage*
TBQ score
(patient perspective)
Numeric 0 Mean/SD 26.8 18.6
Median/IQR 20.0 [15.0; 33.0]
log(TBQ score + 1)
(patient perspective)
Numeric 0 Mean/SD 3.2 0.6
Median/IQR 3.0 [2.8; 3.5]
VAS rating (GP perspective) Numeric 1 Mean/SD 4.5 1.7
Median/IQR 4.0 [3.0;6.0]
Patient’s age Numeric 0 Mean/SD 72.9 12.0
Median/IQR 74.2 [65.9; 81.8]
Patient’s gender is male Logical 0 TRUE 428 48.2
Location of practice Category 0 Urban 383 43.1
Semi-urban 361 40.7
Rural 144 16.2
Marital status Category 0 Single 85 9.6
Married 437 49.2
Separated/
divorced
150 16.9
Widow 216 24.3
Highest level of schooling achieved Category 1 Compulsory
education
195 22.0
Upper secondary
level
337 38.0
Tertiary level 355 40.0
Number of CC (GP’s assessment) Numeric 4 Mean/SD 7.2 2.9
Median/IQR 7.0 [5.0;8.2]
CIRS Numeric 1 Mean/SD 1.7 0.4
Median/IQR 1.7 [1.5–2.0]
Total number of different pharmacological treatment the patient is
currently taking
Numeric 0 Mean/SD 7.7 3.5
Median/IQR 7.0 [5.0;10.0]
Use of a pillbox (dispenser) Logical 0 TRUE 405 45.6
Home-based care (patient report) Logical 10 TRUE 94 10.6
Total EQ-5D-3 L score Numeric 0 Mean/SD 69.9 17.6
Median/IQR 70.5 [62.4;78.3]
EQ-5D-3 L health scale (VAS, 0–100) Numeric 0 Mean/SD 63.2 19.3
Median/IQR 65.0 [50.0;80.0]
Deprivation score (DipCare) Numeric 0 Mean/SD 1.2 0.9
Median/IQR 0.9 [0.5;1.8]
Health literacy score (HLS EU 6) Numeric 577 Mean/SD 2.9 0.5
Median/IQR 2.8 [2.7;3.2]
Hypertension (ICPC:K85,86) Logical 0 TRUE 657 74.0
Cardiovascular risk factors (ICPC:K22) Logical 0 TRUE 391 44.0
Diabetes (ICPC: T89,90) Logical 0 TRUE 277 31.2
Obesity (ICPC: T82) Logical 0 TRUE 274 30.9
Ischemic heart disease (ICPC: K74,76) Logical 0 TRUE 258 29.1
Depression (ICPC: P76) Logical 0 TRUE 228 25.7
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Younger, educated patients, those with a lower quality of
life, a higher deprivation score and lower health literacy
reported higher self-perceived burden of treatment. Suf-
fering from diabetes or atrial fibrillation was also inde-
pendently associated with higher patients’ self-reported
burden of treatment. From the GPs’ perspective, burden
of treatment was also perceived to be higher in younger
patients and in those suffering from atrial fibrillation.
Medical factors (number of chronic conditions, number
of drugs…) rather than social factors (deprivation, liter-
acy…) appeared to be more strongly associated with
GPs’ perceptions of their patients’ burden of treatment.
GPs seemed to integrate the notion of deprivation or
lower health literacy in their estimation of their patients’
burden of treatment only to a minor degree.
The most important finding in our study is the associ-
ation between higher burden of treatment and younger age.
We hypothesize that this may be due to a higher impact of
multimorbidity on an active professional life: younger pa-
tients may have more difficulties integrating the workload
of treatment for several chronic conditions into an active
professional life. Alternatively, older patients’ self-perceived
burden of treatment may be lower due to a higher accept-
ance of their chronic conditions with time, or as a conse-
quence of their social education (readiness to accept a
negative condition). Most previous studies on multimorbid-
ity were conducted in older populations only and this may
be the reason why our finding is new. [1, 34, 35].
A second important finding is the difference in factors
associated with burden of treatment between patients
and GPs. While patients’ estimates of their burden of
treatment were predominantly associated with psycho-
logical and socioeconomic factors (deprivation, health
literacy and lower quality of life), GPs’ perspectives were
more strongly associated with medical factors such as
the number of chronic conditions and drugs. In order to
achieve realistic goals, practice patient-centered care and
apply shared decision-making care models - as proposed
by Muth et al. - GPs should probably explore their pa-
tients’ self-perceived burden of treatment, rather than
rely only on their own assessment. [36, 37] Our results
are in line with other publications showing that patient-
provider concordance needs to be improved. [38, 39]
Caring for multimorbid patients is a complex task
which needs an understanding beyond the simple com-
pilation of chronic conditions or bio-medical concepts.
[40] However, our study shows that GPs estimates of the
burden of treatment most strongly relate to such factors.
As multimorbidity is a long-term challenge and needs a
paradigm change “from cure to care” or “from guidelines
to mindlines” the integration and correct estimation of
patients’ burden of treatment is important. [11, 41] This
includes patient’s ability for self-management and an un-
derstanding of factors that may limit this ability, such as
low health literacy. [42, 43] Our study shows the import-
ance of patient-centered care: the role of GPs is to
Table 1 Characteristics of the 888 included patients and main results regarding associated factors (Continued)
Description Type N missing
values
Value Frequency* Percentage*
Knee osteoarthritis (ICPC:L90) Logical 0 TRUE 223 25.1
Pain general (ICPC:A01) Logical 0 TRUE 198 22.3
Atrial Fibrillation (ICPC:K78) Logical 0 TRUE 195 22.0
Fig. 1 Overall TBQ score
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explore patients’ burden and limits, including socio-
economic and psychological factors.
An important challenge is to improve treatment ad-
herence in multimorbid patients. This has an impact on
long-term outcomes and health care costs. Indeed,
higher burden of treatment is associated with poorer
treatment adherence. [18, 44] Therefore, a better under-
standing of factors associated with patient’s ability and
workload is likely to help improve treatment adherence.
[40] We need to “start treatment for patients not for dis-
eases” as proposed by May. [45] When starting new
treatments, we also need to weigh the added burden of
treatment against the (sometimes-small) effects of these
new treatments in multimorbid patients. Therefore, for
every potential treatment (e.g. recommended by a guide-
line), GPs should consider the potential added burden of
treatment and discuss and weigh this with their patients.
Evidence from the literature confirms that better know-
ledge of patients’ needs and goals, improved relationship,
patient-centered care and shared decisions between GPs
and patients improve treatment adherence and patients’
satisfaction as well as outcomes. [17, 46–48] Therefore, it
seems essential to integrate individual patients’ perceived
burden of treatment into every decision about the long-
term management in the context of multimorbidity.
Another finding of our study suggests that burden of
treatment is particularly high for diabetic patients. Yet
the literature on diabetes rarely integrates burden of
treatment factors such as emotional elements, diet or
food constraints, which are highly important for patients
with diabetes. [17, 49] We hypothesize that the burden
of treatment is particularly high for patients with dia-
betes because the treatment requires activities in mul-
tiple domains, e.g. daily serum glucose controls,
adaptation of diet, physical exercise. This has an import-
ant impact on social life and attitudes.
Atrial fibrillation was also associated with a higher
burden of treatment. This might be explained by the
need for anticoagulation, which has an impact on drug
and food interactions or on the number of GP visits
required.
Strengths
Our study is one of the first quantitative studies to use
Tran’s TBQ score in a large population of multimorbid
patients in primary care. Furthermore, to the best of our
knowledge it is the first study to integrate factors associ-
ated with burden of treatment both from GPs’ and from
patients’ perspectives.
Another strength is the inclusion of younger patients in
our sample. Most studies on multimorbidity usually only
select older patients. And our study covers a diverse sam-
ple from French and German-speaking regions, recruited
over most of an entire country, thus better reflecting usual
care in multimorbid patients in primary care.
Finally, our study assessed an important range of social as
well as medical variables potentially associated with burden
of treatment in multimorbid patients in PC, thus covering a
wide range of dimensions of the burden of treatment.
Limitations
Our study has some limitations. First the French-version
of the TBQ, developed in 2012, has not been used else-
where. We created a German version of the TBQ using
careful translation-back-translation of the validated
French version, but did not validate this version per-se.
Furthermore, the original TBQ was developed and vali-
dated for face to face interviews and we cannot exclude
some differences when using phone interviews. Because
the TBQ was not developed for this purpose, and also to
limit the study burden for GPs, we used a VAS to assess
burden of treatment from the GPs perspective and not
the TBQ. This may have had an influence on the com-
parison between the two perspectives. In addition, this
method precluded any direct comparison between GPs’
and patients’ TBQ scores. Finally, there were many miss-
ing values on the health literacy score. We used multiple
imputations to adjust for this, which may have influ-
enced our findings.
Conclusions
Both from patients’ and GPs’ perspectives burden of
treatment appears to be higher in younger patients.
Fig. 2 TBQ score Barblot
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Whereas for patients burden of treatment is associated
with socio-economic and psychological factors, GPs as-
sessment appears to be associated with medical factors
such as number or severity of chronic conditions and
number of drugs. These findings offer new guidance to
improve patient-centered care. Indeed, including socio-
economic and psychological factors or relying on patients’
self-perception is likely to improve GPs’ assessments of
their multimorbid patients’ burden of treatment. A more
adequate estimate of this burden may help GPs weigh the
benefits of any added treatment against the risk of adding
to this burden thus threatening adherence to care. Further
research should identify pragmatic ways of integrating the
assessment of patients’ burden of treatment in the routine
care of multimorbid patients seen in primary care.
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